Articles published by Immuron Limited
Travelan® Phase 2 Study Results Published
October 13, 2026
Immuron to launch PROIBS® in the United States
September 04, 2026
Immuron Reports FY26 Preliminary Results
August 28, 2026
Immuron Double Digit 3Q Sales Growth
April 17, 2026
Immuron Reports HY26 Results and Strategic Reset
February 25, 2026
Immuron Reports Continued Sales Growth
January 19, 2026
Immuron New U.S. Department of Defense Award & Clinical Trial Update
December 03, 2025
Immuron IMM-529 IND approved by FDA
November 05, 2025
Immuron Announces Clinical Trial Update
October 31, 2025
Immuron Q1 FY26 YoY growth
October 13, 2025
Immuron Submits IMM-529 IND to FDA
October 08, 2025
Immuron Letter to Shareholders – Projects Update
October 02, 2025
Immuron partners with InvestorHub
August 26, 2025
Immuron Letter to Shareholders: Projects Update
May 30, 2025
Immuron Travelan® highest sales in history
April 10, 2025
Immuron Travelan® continued strong sales growth
January 17, 2025
Immuron Announces Travelan® Clinical Trial Update
January 14, 2025
Immuron Travelan® continued strong sales growth
October 15, 2024